DELFEN Drug Patent Profile
Which patents cover Delfen, and when can generic versions of Delfen launch?
Delfen is a drug marketed by Personal Prods and is included in one NDA.
The generic ingredient in DELFEN is nonoxynol-9. There is one drug master file entry for this compound. Additional details are available on the nonoxynol-9 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DELFEN?
- What are the global sales for DELFEN?
- What is Average Wholesale Price for DELFEN?
Summary for DELFEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 44 |
| Patent Applications: | 6,093 |
| DailyMed Link: | DELFEN at DailyMed |
US Patents and Regulatory Information for DELFEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personal Prods | DELFEN | nonoxynol-9 | AEROSOL;VAGINAL | 014349-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
